Lawesson's reagent → HCID 57642343, 화합물

반응식

[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[C:16]([F:21])[C:17]([O:19][CH3:20])=[CH:18][C:13]=2[NH:12][C:11](=O)[CH2:10][N:9]=1.COC1C=CC(P2(SP(C3C=CC(OC)=CC=3)(=S)S2)=[S:32])=CC=1>>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:14]2[CH:15]=[C:16]([F:21])[C:17]([O:19][CH3:20])=[CH:18][C:13]=2[NH:12][C:11](=[S:32])[CH2:10][N:9]=1

참가 물질

반응물 2

HCID 87949Lawesson's reagent

HCID 57642349HCID 57642349, 화합물

생성물 1

HCID 57642343HCID 57642343, 화합물

실험 절차

5-(2-chlorophenyl)-1,3-dihydro-7-fluoro-8-methoxy-2H-1,4-benzodiazepin-2-thione (IIa) was prepared by reacting 0.0284 moles of 5-(2-chlorophenyl)-1,3-dihydro-7-fluoro-8-methoxy-2H-1,4-benzodiazepin-2-one (Ia) with Lawesson's reagent in a manner analogous to Example 38.

출처 및 근거

ORD 기록: ord-aa9fc261143f401d99b26d57576c5a0e
출처 데이터셋: uspto-grants-2009_04
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US07524840B2

반응 노트

불러오는 중…